680 related articles for article (PubMed ID: 24062250)
1. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
2. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
[TBL] [Abstract][Full Text] [Related]
3. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
[TBL] [Abstract][Full Text] [Related]
4. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
[TBL] [Abstract][Full Text] [Related]
6. Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia.
Castellani LN; Peppler WT; Sutton CD; Whitfield J; Charron MJ; Wright DC
Psychoneuroendocrinology; 2017 Aug; 82():38-45. PubMed ID: 28500893
[TBL] [Abstract][Full Text] [Related]
7. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
[TBL] [Abstract][Full Text] [Related]
8. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
9. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ
Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124
[TBL] [Abstract][Full Text] [Related]
10. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
[TBL] [Abstract][Full Text] [Related]
12. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
[TBL] [Abstract][Full Text] [Related]
13. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
Lee Y; Wang MY; Du XQ; Charron MJ; Unger RH
Diabetes; 2011 Feb; 60(2):391-7. PubMed ID: 21270251
[TBL] [Abstract][Full Text] [Related]
14. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function.
Sørensen H; Winzell MS; Brand CL; Fosgerau K; Gelling RW; Nishimura E; Ahren B
Diabetes; 2006 Dec; 55(12):3463-9. PubMed ID: 17130493
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
[TBL] [Abstract][Full Text] [Related]
18. Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes.
Claus TH; Pan CQ; Buxton JM; Yang L; Reynolds JC; Barucci N; Burns M; Ortiz AA; Roczniak S; Livingston JN; Clairmont KB; Whelan JP
J Endocrinol; 2007 Feb; 192(2):371-80. PubMed ID: 17283237
[TBL] [Abstract][Full Text] [Related]
19. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
